Xinwei D. Jia

1.6k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Xinwei D. Jia is a scholar working on Gastroenterology, Surgery and Pharmacology. According to data from OpenAlex, Xinwei D. Jia has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Gastroenterology, 8 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Xinwei D. Jia's work include Gastrointestinal motility and disorders (13 papers), Gastroesophageal reflux and treatments (4 papers) and Intestinal Malrotation and Obstruction Disorders (4 papers). Xinwei D. Jia is often cited by papers focused on Gastrointestinal motility and disorders (13 papers), Gastroesophageal reflux and treatments (4 papers) and Intestinal Malrotation and Obstruction Disorders (4 papers). Xinwei D. Jia collaborates with scholars based in United States, Chile and Singapore. Xinwei D. Jia's co-authors include Caroline B. Kurtz, Jeffrey M. Johnston, Mark G. Currie, Steven J. Shiff, Bernard J. Lavins, Anthony Lembo, Harvey Schneier, James E. MacDougall, James Shao and Donald A. Fitch and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Xinwei D. Jia

19 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

2012 340 citations William D. Chey, Anthony Lembo et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinwei D. Jia United States	9	878	629	205	114	104	20	1.2k
Duane Burton United States	24	859 1.0×	713 1.1×	406 2.0×	94 0.8×	29 0.3×	53	1.6k
Yukiomi Nakade Japan	22	285 0.3×	307 0.5×	227 1.1×	185 1.6×	22 0.2×	79	1.4k
Joris H. De Maeyer Belgium	13	440 0.5×	282 0.4×	145 0.7×	47 0.4×	24 0.2×	24	787
Fernando Ochoa‐Cortés Mexico	13	378 0.4×	196 0.3×	229 1.1×	25 0.2×	55 0.5×	33	819
Leonard S. Dove United States	12	502 0.6×	266 0.4×	174 0.8×	93 0.8×	23 0.2×	22	809
Klaas Prins Belgium	15	505 0.6×	277 0.4×	171 0.8×	19 0.2×	36 0.3×	25	804
Ian Spreadbury Canada	12	263 0.3×	106 0.2×	222 1.1×	32 0.3×	28 0.3×	17	777
Akito Nishida Japan	17	330 0.4×	365 0.6×	173 0.8×	95 0.8×	8 0.1×	43	951
R Takayanagi Japan	11	285 0.3×	116 0.2×	187 0.9×	29 0.3×	17 0.2×	22	614
Chandar Singaram United States	16	237 0.3×	259 0.4×	98 0.5×	34 0.3×	60 0.6×	26	787

Countries citing papers authored by Xinwei D. Jia

Since Specialization

Citations

This map shows the geographic impact of Xinwei D. Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinwei D. Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinwei D. Jia more than expected).

Fields of papers citing papers by Xinwei D. Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinwei D. Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinwei D. Jia. The network helps show where Xinwei D. Jia may publish in the future.

Co-authorship network of co-authors of Xinwei D. Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Xinwei D. Jia. A scholar is included among the top collaborators of Xinwei D. Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinwei D. Jia. Xinwei D. Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lacy, Brian E., Ron Schey, Steven J. Shiff, et al.. (2015). Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS ONE. 10(7). e0134349–e0134349. 56 indexed citations

Lacy, Brian E., Anthony Lembo, Ron Schey, et al.. (2014). Sa2008 Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results. Gastroenterology. 146(5). S–353. 1 indexed citations

Jia, Xinwei D., Jenny S. Choy, Zhen‐Du Zhang, et al.. (2013). Extent of load-independence of pressure-normalized stress in swine. Experimental Biology and Medicine. 238(7). 821–829. 1 indexed citations

Camilleri, Michael, Anthony Lembo, Bernard J. Lavins, et al.. (2013). Mo2054 Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation. Gastroenterology. 144(5). S–728. 2 indexed citations

Rao, Satish S.C., Anthony Lembo, Steven J. Shiff, et al.. (2012). A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation. The American Journal of Gastroenterology. 107(11). 1714–1724. 293 indexed citations

Chey, William D., Anthony Lembo, Bernard J. Lavins, et al.. (2012). Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety. The American Journal of Gastroenterology. 107(11). 1702–1712. 340 indexed citations breakdown →

Schoenfeld, Philip, William D. Chey, Bernard J. Lavins, et al.. (2012). Mo1856 Linaclotide Significantly Improved Abdominal Pain Compared With Placebo in Patients With Irritable Bowel Syndrome Regardless of Baseline Pain Severity in Two Phase 3 Trials. Gastroenterology. 142(5). S–701. 4 indexed citations

Chey, William D., Caroline B. Kurtz, Robyn T. Carson, et al.. (2012). Tu1068 Effects of Linaclotide Treatment on Patient-Reported Ratings of Change for Symptoms of Irritable Bowel Syndrome With Constipation (IBS-C): Pooled 12-Week Findings From Two Phase 3 Trials. Gastroenterology. 142(5). S–737. 4 indexed citations

Schoenfeld, Philip, Lin Chang, Robyn T. Carson, et al.. (2012). Tu1069 Do Baseline Factors Contribute to Treatment Satisfaction in Patients With Chronic Constipation Treated With Linaclotide vs Placebo?. Gastroenterology. 142(5). S–737. 3 indexed citations

10.

Spiegel, Brennan, Caroline B. Kurtz, Valerie Williams, et al.. (2012). Sa1094 Developing Benchmarks for Clinically Meaningful Change for IBS-C Symptoms Using Data From Two Phase 3 Trials of Linaclotide. Gastroenterology. 142(5). S–214. 2 indexed citations

11.

Lembo, Anthony, Harvey Schneier, Steven J. Shiff, et al.. (2011). Two Randomized Trials of Linaclotide for Chronic Constipation. New England Journal of Medicine. 365(6). 527–536. 270 indexed citations

12.

Lembo, Anthony, Harvey Schneier, Bernard J. Lavins, et al.. (2011). The Effect of Linaclotide on Measures of Abdominal and Bowel Symptoms in Patients With Chronic Constipation and Abdominal Pain: Pooled Results From Two Phase 3 Trials. Gastroenterology. 140(5). S–49. 2 indexed citations

13.

Lembo, Anthony, Harvey Schneier, Bernard J. Lavins, et al.. (2010). Efficacy and Safety of Once-daily Linaclotide Administered Orally for 12-Weeks in Patients with Chronic Constipation: Pooled Results from 2 Randomized, Double-blind, Placebo-controlled Phase 3 Trials. The American Journal of Gastroenterology. 105. S495–S495. 2 indexed citations

14.

Lembo, Anthony, Harvey Schneier, Bernard J. Lavins, et al.. (2010). 286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials. Gastroenterology. 138(5). S–53. 16 indexed citations

15.

Lieberman, Jeffrey A., Kelly Papadakis, John G. Csernansky, et al.. (2008). A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia. Neuropsychopharmacology. 34(5). 1322–1329. 117 indexed citations

16.

Grossberg, George T., Facundo Manes, Ricardo Allegri, et al.. (2008). P4‐405: A multinational, randomized, double‐blind, placebo‐controlled, parallel‐group trial of memantine extended‐release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_24). 10 indexed citations

17.

Zhao, Qinying, et al.. (2003). Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil. The Journal of Clinical Pharmacology. 43(2). 180–186. 22 indexed citations

18.

Jia, Xinwei D., et al.. (2003). On weak consistency in linear models with equi-correlated random errors. Statistics. 37(6). 463–473.

19.

Nedelman, Jerry & Xinwei D. Jia. (1998). An extension of satterth waite's approximation applied to pharmacokinetics. Journal of Biopharmaceutical Statistics. 8(2). 317–328. 51 indexed citations

20.

Jia, Xinwei D., et al.. (1996). Errors in time in pharmacokinetic studies. Journal of Biopharmaceutical Statistics. 6(3). 303–318. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact